Worker deaths probed at Dr. Reddy's plants

Investigations are underway into a mid-March fire at a Dr. Reddy's plant in which two contract workers died. Separately, Indian officials have brought charges against the drugmaker for employee deaths at another Indian plant.

Authorities are at the early stages of an investigation into last month's fire. They are currently waiting for Dr. Reddy's to provide safety-related information. The earlier incident occurred in late December at an API-making facility in the Medak District. Employees working with Omeprazole powder in a cleanroom reportedly inhaled nitrogen gas, leading to their deaths. No other employees were affected.

Officials have just filed charges of equipment and safety violations in addition to negligence. Dr. Reddy's could face fines if the court finds the violations led to the deaths. Manufacturing continues at the plant, though the area in question remains closed off. Multiple authorities, including police, continue their investigations.

- here's the story

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.